Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Trial details
- Registry ID
- NCT05896670
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670 | Oculis | Phase 2 | Completed | 2024-03-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |